Abstract
AbstractLaboratoires Théa has decided to create a new entity called Théa Open Innovation which aims to identify, assess and value start‐ups, University and research teams' best innovative solutions to help develop new treatments for eye diseases.By putting license agreements and/or participations in place, Théa Open Innovation brings: its expertise in ophthalmology development and the necessary funding to these partners to achieve proof of concept in humans and Laboratoires Théa's ability to drive the regulatory phases of product development and commercialization. Small & medium sized companies, innovative start‐ups, researchers or academics can team up with Théa Open Innovation to deliver the solutions of tomorrow to patients and practitioners.Managed by Henri and Jean‐Frédéric Chibret, Laboratoires Théa is a major player in ophthalmology, with a presence in 70 countries around the world, more than 25 subsidiaries, and a turnover of over 500 M€.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
